Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset.
Rutger HeinenMartijn D SteenwijkFrederik BarkhofJohannes Matthijs BiesbroekWiesje Maria van der FlierHugo J KuijfNiels D PrinsHugo VrenkenGeert Jan BiesselsJeroen de Bressernull nullPublished in: Scientific reports (2019)
White matter hyperintensities (WMHs) are a common manifestation of cerebral small vessel disease, that is increasingly studied with large, pooled multicenter datasets. This data pooling increases statistical power, but poses challenges for automated WMH segmentation. Although there is extensive literature on the evaluation of automated WMH segmentation methods, such evaluations in a multicenter setting are lacking. We performed WMH segmentations in sixty patients scanned on six different magnetic resonance imaging (MRI) scanners (10 patients per scanner) using five freely available and fully-automated WMH segmentation methods (Cascade, kNN-TTP, Lesion-TOADS, LST-LGA and LST-LPA). Different MRI scanner vendors and field strengths were included. We compared these automated WMH segmentations with manual WMH segmentations as a reference. Performance of each method both within and across scanners was assessed using spatial and volumetric correspondence with the reference segmentations by Dice's similarity coefficient (DSC) and intra-class correlation coefficient (ICC) respectively. We found the best performance, both within and across scanners, for kNN-TTP, followed by LST-LPA and LST-LGA, with worse performance for Lesion-TOADS and Cascade. Our findings can serve as a guide for choosing a method and also highlight the importance to further improve and evaluate consistency of methods in a multicenter setting.
Keyphrases
- deep learning
- magnetic resonance imaging
- white matter
- end stage renal disease
- machine learning
- convolutional neural network
- high throughput
- chronic kidney disease
- newly diagnosed
- ejection fraction
- diffusion weighted imaging
- contrast enhanced
- artificial intelligence
- peritoneal dialysis
- systematic review
- randomized controlled trial
- multiple sclerosis
- patient reported outcomes
- magnetic resonance
- open label
- blood brain barrier
- phase iii